Every few months, azelaic acid gets rediscovered as "the ingredient nobody talks about." That framing is starting to wear thin — it's been FDA-approved since the mid-1990s and there are now more than forty randomised trials on it. The more interesting question isn't whether azelaic acid is quietly great. It's which of the several things it's marketed for actually hold up in the studies, and how long you'd realistically wait to see them.
Short version: three things hold up well. A fourth — general "anti-ageing" — mostly doesn't.
What azelaic acid actually is
Azelaic acid is a small dicarboxylic acid that occurs naturally in grains like wheat, rye and barley. On skin, it works through several mechanisms at once rather than doing one dramatic thing: it's mildly antimicrobial against acne-relevant bacteria, it dials down inflammatory signalling (including the NF-κB pathway and cytokines like IL-1β and TNF-α), it inhibits tyrosinase — the enzyme that produces melanin — and it acts as a mild antioxidant. That "several things at once, none of them extreme" profile is why it ends up on a shortlist for people who can't tolerate retinoids or hydroquinone, and why it works on such a mixed bag of conditions (PMC review of azelaic acid mechanisms and clinical applications).
What the trials actually show
A 2023 systematic review in the Journal of Cosmetic Dermatology pulled together 43 randomised controlled trials of azelaic acid across four conditions: acne, rosacea, melasma, and skin ageing (King et al., 2023, via PubMed). The results are useful precisely because they're uneven.
| Condition | What the trials found |
|---|---|
| Papulopustular rosacea | Twelve weeks of azelaic acid significantly improved redness, inflammatory bump counts and overall clearance versus vehicle. In head-to-head trials, it outperformed 0.75% metronidazole on erythema and lesion count. |
| Acne | Effective versus vehicle for inflammatory lesions; broadly comparable to other topical acne treatments in the trials included. |
| Melasma | 20% azelaic acid outperformed vehicle for both severity and global improvement, and beat 2% hydroquinone on global improvement across seven melasma trials. |
| "Anti-ageing" | The signal here was thin — the review flagged evidence for wrinkle or general-ageing endpoints as weak. |
The rosacea finding is the one to notice. Metronidazole has been the default prescription topical for rosacea for decades, and azelaic acid at 15% did better on the erythema endpoint in the studies compared. That's not "azelaic acid is a miracle" — it's "the ingredient people treat as second-string may actually be first-string for this specific job."
Why "azelaic acid didn't work for me" often means "you gave it three weeks"
The frustrating truth in almost every trial is the timeline. Meaningful improvement in rosacea, acne and melasma studies typically shows up around 12 to 16 weeks of consistent use, with some pigmentation shift visible from around week 6 to 9 in combination-therapy studies (PMC review). Compared to something like benzoyl peroxide, which can visibly calm a pustule in days, azelaic acid works on a slower, more structural clock — it's rebalancing inflammation and pigment production rather than aggressively stripping or bleaching. Most people who quietly write it off at week four never actually reached the window where the trial data starts to move.
If you want a rule of thumb: don't judge azelaic acid before three months.
How is OTC 10% different from prescription 15% or 20%?
This is the part where the marketing and the evidence part ways slightly. The well-studied formulations are:
- 15% gel — FDA-approved for rosacea, prescription in most markets including Singapore.
- 20% cream — approved for acne, also prescription.
- Foam and other newer vehicles — approved variants, some designed to improve tolerability.
Most of the over-the-counter serums sold as "azelaic acid" — including several popular K-beauty and indie brand versions — sit at 10%, sometimes lower. Ten percent isn't nothing; it's the strength used in some cosmetic formulations and there's clinical work at that level too. But when someone quotes the 43-trial evidence, the majority of those trials are at 15% or 20%, and the smaller molecule differences in vehicle (gel vs cream vs foam) also affect how much actually gets into skin. It's fair to try a 10% first, especially if you're new to it or reactive. Just don't assume a 10% OTC serum and a 15% prescription gel are the same product with a different label.
Who azelaic acid genuinely suits
The people who tend to benefit most, based on how the studies are structured:
- Persistent low-grade redness across cheeks and nose, with occasional papules — the papulopustular rosacea picture.
- Adult hormonal or inflammatory acne that hasn't responded well to salicylic acid or benzoyl peroxide, especially where the marks after a breakout are the real complaint.
- Melasma or post-inflammatory hyperpigmentation, particularly on medium-to-deep skin tones where hydroquinone or aggressive acids raise a rebound-pigmentation risk.
- Anyone pregnant or breastfeeding who's been told to stop retinoids and hydroquinone — azelaic acid is generally considered safe in pregnancy (this is one of the reasons it gets prescribed a lot in that window), though as always, confirm with your own doctor.
The people it suits less: dramatic, cystic acne (needs stronger systemic work), sun-damage type dark spots that are more solar lentigines than melasma (respond better to different actives), and anyone expecting fast, visible clearing in a fortnight.
Side effects worth planning for
Mild stinging, tingling, dryness and a bit of pinkness in the first one to two weeks is common and usually settles. About 1–5% of people in trials had enough irritation to matter. The practical playbook: start every second night, apply to dry skin (damp skin amplifies stinging), pair with a plain ceramide moisturiser rather than piling on another active, and don't layer it the same evening as a retinoid or a high-strength AHA for the first month.
Sunscreen is non-negotiable — not because azelaic acid photosensitises the way an AHA does, but because you're treating pigment, and any pigment protocol without daily SPF is quietly working against itself.
The realistic verdict
Azelaic acid isn't a hero ingredient in the retinoid sense. What it is, based on the actual trial record, is one of the few topicals with solid randomised evidence for three different problems at once — the kind of ingredient that earns a permanent spot for people whose skin sits at the intersection of red, bumpy and marked, rather than firmly in one camp. It's slow. It's uneventful. It doesn't announce itself. But at three months in, a lot of people notice their skin looks steadier in a way nothing else did.
That's the shape of the evidence — and it's a more useful thing to know than another round of "underrated ingredient" headlines.
If you're going to try azelaic acid, commit to three months before you decide anything. It's slow, unglamorous and doesn't do fireworks — but the evidence at week 12 is the reason it keeps showing up on dermatologists' shortlists.
